Improving access to clinical trials when biopsies are required

By: | Tags: , , | Comments: 0 | January 4th, 2016

The requirement for tumor tissue specimens and associated analyses in order to participate in clinical trials appears to be a significant barrier to clinical trial enrollment and may delay treatment. Potential solutions to reducing or eliminating these barriers include routine tissue banking at diagnosis, easing use of available diagnostic samples, development of less invasive tests, faster turnaround time at central laboratories or allowing for local testing and more resources for timely tissue collection.

      

Menu Title

Thank you very much for your submission! We will get back to you as soon as possible!